Single Source · Quartz
This is one outlet's own report from Quartz — the article as it was filed. Other outlets are covering the same event; open the full story to compare every source side by side.
See the full story · 13 sourcesAIPROPX ReportQuartz · 1h ago
FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer
The drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial
Share
◆ AIPROPX index record
- Region
- Other
- In this story
- 10 of 15 reports · 13 outlets
- Detected names
- FDARevolution MedicinesRasonque
AIPROPX is an independent multi-source news index — we track, compare, and connect coverage from across the web into one place you won't find anywhere else.